Loading…
Hypertension and erectile dysfunction: The role of endovascular therapy in Asia
The prevalence of erectile dysfunction (ED) is above 40% in both Asian and non‐Asian male populations after the age of 40 years. The prevalence of ED among hypertensive patients is approximately double than that in normotensive population. Pelvic arterial insufficiency is the predominant cause of ED...
Saved in:
Published in: | The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2021-03, Vol.23 (3), p.481-488 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4813-bf5698c22ff1e6298d79bcccaa8b0f10c07c2d8ee43f22ae0e28ddc10c2389083 |
---|---|
cites | cdi_FETCH-LOGICAL-c4813-bf5698c22ff1e6298d79bcccaa8b0f10c07c2d8ee43f22ae0e28ddc10c2389083 |
container_end_page | 488 |
container_issue | 3 |
container_start_page | 481 |
container_title | The journal of clinical hypertension (Greenwich, Conn.) |
container_volume | 23 |
creator | Wang, Tzung‐Dau Lee, Chih‐Kuo Chia, Yook‐Chin Tsoi, Kelvin Buranakitjaroen, Peera Chen, Chen‐Huan Cheng, Hao‐Min Tay, Jam Chin Teo, Boon Wee Turana, Yuda Sogunuru, Guru Prasad Wang, Ji‐Guang Kario, Kazuomi |
description | The prevalence of erectile dysfunction (ED) is above 40% in both Asian and non‐Asian male populations after the age of 40 years. The prevalence of ED among hypertensive patients is approximately double than that in normotensive population. Pelvic arterial insufficiency is the predominant cause of ED in men aged over 50 years. Stenosis in any segment of the iliac–pudendal–penile arterial system, which is considered an erectile‐related arterial axis, could lead to ED. Pharmacotherapy with lifestyle modification is effective in alleviating sexual dysfunction, yet a substantial number of patients still develop ED. Given the established applicability of angioplasty for the entire iliac–pudendal–penile arterial system, penile duplex ultrasound, and pelvic computed tomography angiography could be considered as the routine screening tools in ED patients with poor response to phosphodiesterase‐5 inhibitors. Endovascular therapy for pelvic arterial insufficiency‐related ED has been shown to be a safe and effective treatment option in patients who have anatomically suitable vessels and functionally significant stenoses. Clinical improvement was achieved in over 60% of patients at one year following pelvic angioplasty in the PERFECT registry from Taiwan. A 30%‐40% restenosis rate in distal internal pudendal and penile arteries remains a hurdle. Angioplasty for pelvic arterial occlusive disease could be considered as a viable approach to arteriogenic ED. |
doi_str_mv | 10.1111/jch.14123 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d5a5c54837654291bd9741651f2c7fdc</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d5a5c54837654291bd9741651f2c7fdc</doaj_id><sourcerecordid>2470025164</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4813-bf5698c22ff1e6298d79bcccaa8b0f10c07c2d8ee43f22ae0e28ddc10c2389083</originalsourceid><addsrcrecordid>eNp1kc1O3DAURq2qVaHQRV-gyrJdBPwbO11UQiPaoUJiA2vLsa-ZjDL21E6o8vYYQhEs8MZX3z06tvQh9IXgE1LO6dZuTggnlL1Dh0QKUksim_dlFpTXTUkO0KectxgLxlr8ER0wxgiXRByiq_W8hzRCyH0MlQmuggR27Aeo3Jz9FMocw4_qegNViiWNvoLg4p3JdhpMqsYNJLOfqz5UZ7k3x-iDN0OGz0_3Ebr5dX69WteXV78vVmeXteWKsLrzommVpdR7Ag1tlZNtZ601RnXYE2yxtNQpAM48pQYwUOWcLQvKVIsVO0IXi9dFs9X71O9MmnU0vX4MYrrVJo29HUA7YYQVXDHZCE5b0rlWctII4qmV3tni-rm49lO3A2chjMkMr6SvN6Hf6Nt4pxWmrZC8CL49CVL8O0Ee9a7PFobBBIhT1pRLjKkgzQP6fUFtijkn8M_PEKwfytSlTP1YZmG_vvzXM_m_vQKcLsC_0tf8tkn_Wa0X5T3tqqm5</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2470025164</pqid></control><display><type>article</type><title>Hypertension and erectile dysfunction: The role of endovascular therapy in Asia</title><source>Wiley Online Library Open Access</source><source>PubMed Central</source><creator>Wang, Tzung‐Dau ; Lee, Chih‐Kuo ; Chia, Yook‐Chin ; Tsoi, Kelvin ; Buranakitjaroen, Peera ; Chen, Chen‐Huan ; Cheng, Hao‐Min ; Tay, Jam Chin ; Teo, Boon Wee ; Turana, Yuda ; Sogunuru, Guru Prasad ; Wang, Ji‐Guang ; Kario, Kazuomi</creator><creatorcontrib>Wang, Tzung‐Dau ; Lee, Chih‐Kuo ; Chia, Yook‐Chin ; Tsoi, Kelvin ; Buranakitjaroen, Peera ; Chen, Chen‐Huan ; Cheng, Hao‐Min ; Tay, Jam Chin ; Teo, Boon Wee ; Turana, Yuda ; Sogunuru, Guru Prasad ; Wang, Ji‐Guang ; Kario, Kazuomi ; HOPE Asia Network ; the HOPE Asia Network</creatorcontrib><description>The prevalence of erectile dysfunction (ED) is above 40% in both Asian and non‐Asian male populations after the age of 40 years. The prevalence of ED among hypertensive patients is approximately double than that in normotensive population. Pelvic arterial insufficiency is the predominant cause of ED in men aged over 50 years. Stenosis in any segment of the iliac–pudendal–penile arterial system, which is considered an erectile‐related arterial axis, could lead to ED. Pharmacotherapy with lifestyle modification is effective in alleviating sexual dysfunction, yet a substantial number of patients still develop ED. Given the established applicability of angioplasty for the entire iliac–pudendal–penile arterial system, penile duplex ultrasound, and pelvic computed tomography angiography could be considered as the routine screening tools in ED patients with poor response to phosphodiesterase‐5 inhibitors. Endovascular therapy for pelvic arterial insufficiency‐related ED has been shown to be a safe and effective treatment option in patients who have anatomically suitable vessels and functionally significant stenoses. Clinical improvement was achieved in over 60% of patients at one year following pelvic angioplasty in the PERFECT registry from Taiwan. A 30%‐40% restenosis rate in distal internal pudendal and penile arteries remains a hurdle. Angioplasty for pelvic arterial occlusive disease could be considered as a viable approach to arteriogenic ED.</description><identifier>ISSN: 1524-6175</identifier><identifier>EISSN: 1751-7176</identifier><identifier>DOI: 10.1111/jch.14123</identifier><identifier>PMID: 33314715</identifier><language>eng</language><publisher>United States: John Wiley and Sons Inc</publisher><subject>Adult ; Angioplasty ; Asia ; Asian patients ; atherosclerosis ; Erectile Dysfunction - diagnosis ; Erectile Dysfunction - epidemiology ; Erectile Dysfunction - therapy ; Humans ; Hypertension ; Hypertension and Clinical Outcomes ; Male ; Review Paper ; sexual dysfunction ; Taiwan ; vascular disease</subject><ispartof>The journal of clinical hypertension (Greenwich, Conn.), 2021-03, Vol.23 (3), p.481-488</ispartof><rights>2020 The Authors. published by Wiley Periodicals LLC</rights><rights>2020 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4813-bf5698c22ff1e6298d79bcccaa8b0f10c07c2d8ee43f22ae0e28ddc10c2389083</citedby><cites>FETCH-LOGICAL-c4813-bf5698c22ff1e6298d79bcccaa8b0f10c07c2d8ee43f22ae0e28ddc10c2389083</cites><orcidid>0000-0002-1410-9328 ; 0000-0002-3885-6600 ; 0000-0002-7180-3607 ; 0000-0003-1995-0359 ; 0000-0002-4911-8507 ; 0000-0002-9262-0287 ; 0000-0003-4527-0285 ; 0000-0001-5580-7686 ; 0000-0001-8511-1524 ; 0000-0002-8251-4480 ; 0000-0001-7657-4383</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029574/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029574/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,27901,27902,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33314715$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Tzung‐Dau</creatorcontrib><creatorcontrib>Lee, Chih‐Kuo</creatorcontrib><creatorcontrib>Chia, Yook‐Chin</creatorcontrib><creatorcontrib>Tsoi, Kelvin</creatorcontrib><creatorcontrib>Buranakitjaroen, Peera</creatorcontrib><creatorcontrib>Chen, Chen‐Huan</creatorcontrib><creatorcontrib>Cheng, Hao‐Min</creatorcontrib><creatorcontrib>Tay, Jam Chin</creatorcontrib><creatorcontrib>Teo, Boon Wee</creatorcontrib><creatorcontrib>Turana, Yuda</creatorcontrib><creatorcontrib>Sogunuru, Guru Prasad</creatorcontrib><creatorcontrib>Wang, Ji‐Guang</creatorcontrib><creatorcontrib>Kario, Kazuomi</creatorcontrib><creatorcontrib>HOPE Asia Network</creatorcontrib><creatorcontrib>the HOPE Asia Network</creatorcontrib><title>Hypertension and erectile dysfunction: The role of endovascular therapy in Asia</title><title>The journal of clinical hypertension (Greenwich, Conn.)</title><addtitle>J Clin Hypertens (Greenwich)</addtitle><description>The prevalence of erectile dysfunction (ED) is above 40% in both Asian and non‐Asian male populations after the age of 40 years. The prevalence of ED among hypertensive patients is approximately double than that in normotensive population. Pelvic arterial insufficiency is the predominant cause of ED in men aged over 50 years. Stenosis in any segment of the iliac–pudendal–penile arterial system, which is considered an erectile‐related arterial axis, could lead to ED. Pharmacotherapy with lifestyle modification is effective in alleviating sexual dysfunction, yet a substantial number of patients still develop ED. Given the established applicability of angioplasty for the entire iliac–pudendal–penile arterial system, penile duplex ultrasound, and pelvic computed tomography angiography could be considered as the routine screening tools in ED patients with poor response to phosphodiesterase‐5 inhibitors. Endovascular therapy for pelvic arterial insufficiency‐related ED has been shown to be a safe and effective treatment option in patients who have anatomically suitable vessels and functionally significant stenoses. Clinical improvement was achieved in over 60% of patients at one year following pelvic angioplasty in the PERFECT registry from Taiwan. A 30%‐40% restenosis rate in distal internal pudendal and penile arteries remains a hurdle. Angioplasty for pelvic arterial occlusive disease could be considered as a viable approach to arteriogenic ED.</description><subject>Adult</subject><subject>Angioplasty</subject><subject>Asia</subject><subject>Asian patients</subject><subject>atherosclerosis</subject><subject>Erectile Dysfunction - diagnosis</subject><subject>Erectile Dysfunction - epidemiology</subject><subject>Erectile Dysfunction - therapy</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension and Clinical Outcomes</subject><subject>Male</subject><subject>Review Paper</subject><subject>sexual dysfunction</subject><subject>Taiwan</subject><subject>vascular disease</subject><issn>1524-6175</issn><issn>1751-7176</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNp1kc1O3DAURq2qVaHQRV-gyrJdBPwbO11UQiPaoUJiA2vLsa-ZjDL21E6o8vYYQhEs8MZX3z06tvQh9IXgE1LO6dZuTggnlL1Dh0QKUksim_dlFpTXTUkO0KectxgLxlr8ER0wxgiXRByiq_W8hzRCyH0MlQmuggR27Aeo3Jz9FMocw4_qegNViiWNvoLg4p3JdhpMqsYNJLOfqz5UZ7k3x-iDN0OGz0_3Ebr5dX69WteXV78vVmeXteWKsLrzommVpdR7Ag1tlZNtZ601RnXYE2yxtNQpAM48pQYwUOWcLQvKVIsVO0IXi9dFs9X71O9MmnU0vX4MYrrVJo29HUA7YYQVXDHZCE5b0rlWctII4qmV3tni-rm49lO3A2chjMkMr6SvN6Hf6Nt4pxWmrZC8CL49CVL8O0Ee9a7PFobBBIhT1pRLjKkgzQP6fUFtijkn8M_PEKwfytSlTP1YZmG_vvzXM_m_vQKcLsC_0tf8tkn_Wa0X5T3tqqm5</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Wang, Tzung‐Dau</creator><creator>Lee, Chih‐Kuo</creator><creator>Chia, Yook‐Chin</creator><creator>Tsoi, Kelvin</creator><creator>Buranakitjaroen, Peera</creator><creator>Chen, Chen‐Huan</creator><creator>Cheng, Hao‐Min</creator><creator>Tay, Jam Chin</creator><creator>Teo, Boon Wee</creator><creator>Turana, Yuda</creator><creator>Sogunuru, Guru Prasad</creator><creator>Wang, Ji‐Guang</creator><creator>Kario, Kazuomi</creator><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-1410-9328</orcidid><orcidid>https://orcid.org/0000-0002-3885-6600</orcidid><orcidid>https://orcid.org/0000-0002-7180-3607</orcidid><orcidid>https://orcid.org/0000-0003-1995-0359</orcidid><orcidid>https://orcid.org/0000-0002-4911-8507</orcidid><orcidid>https://orcid.org/0000-0002-9262-0287</orcidid><orcidid>https://orcid.org/0000-0003-4527-0285</orcidid><orcidid>https://orcid.org/0000-0001-5580-7686</orcidid><orcidid>https://orcid.org/0000-0001-8511-1524</orcidid><orcidid>https://orcid.org/0000-0002-8251-4480</orcidid><orcidid>https://orcid.org/0000-0001-7657-4383</orcidid></search><sort><creationdate>202103</creationdate><title>Hypertension and erectile dysfunction: The role of endovascular therapy in Asia</title><author>Wang, Tzung‐Dau ; Lee, Chih‐Kuo ; Chia, Yook‐Chin ; Tsoi, Kelvin ; Buranakitjaroen, Peera ; Chen, Chen‐Huan ; Cheng, Hao‐Min ; Tay, Jam Chin ; Teo, Boon Wee ; Turana, Yuda ; Sogunuru, Guru Prasad ; Wang, Ji‐Guang ; Kario, Kazuomi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4813-bf5698c22ff1e6298d79bcccaa8b0f10c07c2d8ee43f22ae0e28ddc10c2389083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Angioplasty</topic><topic>Asia</topic><topic>Asian patients</topic><topic>atherosclerosis</topic><topic>Erectile Dysfunction - diagnosis</topic><topic>Erectile Dysfunction - epidemiology</topic><topic>Erectile Dysfunction - therapy</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension and Clinical Outcomes</topic><topic>Male</topic><topic>Review Paper</topic><topic>sexual dysfunction</topic><topic>Taiwan</topic><topic>vascular disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Tzung‐Dau</creatorcontrib><creatorcontrib>Lee, Chih‐Kuo</creatorcontrib><creatorcontrib>Chia, Yook‐Chin</creatorcontrib><creatorcontrib>Tsoi, Kelvin</creatorcontrib><creatorcontrib>Buranakitjaroen, Peera</creatorcontrib><creatorcontrib>Chen, Chen‐Huan</creatorcontrib><creatorcontrib>Cheng, Hao‐Min</creatorcontrib><creatorcontrib>Tay, Jam Chin</creatorcontrib><creatorcontrib>Teo, Boon Wee</creatorcontrib><creatorcontrib>Turana, Yuda</creatorcontrib><creatorcontrib>Sogunuru, Guru Prasad</creatorcontrib><creatorcontrib>Wang, Ji‐Guang</creatorcontrib><creatorcontrib>Kario, Kazuomi</creatorcontrib><creatorcontrib>HOPE Asia Network</creatorcontrib><creatorcontrib>the HOPE Asia Network</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>The journal of clinical hypertension (Greenwich, Conn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Tzung‐Dau</au><au>Lee, Chih‐Kuo</au><au>Chia, Yook‐Chin</au><au>Tsoi, Kelvin</au><au>Buranakitjaroen, Peera</au><au>Chen, Chen‐Huan</au><au>Cheng, Hao‐Min</au><au>Tay, Jam Chin</au><au>Teo, Boon Wee</au><au>Turana, Yuda</au><au>Sogunuru, Guru Prasad</au><au>Wang, Ji‐Guang</au><au>Kario, Kazuomi</au><aucorp>HOPE Asia Network</aucorp><aucorp>the HOPE Asia Network</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypertension and erectile dysfunction: The role of endovascular therapy in Asia</atitle><jtitle>The journal of clinical hypertension (Greenwich, Conn.)</jtitle><addtitle>J Clin Hypertens (Greenwich)</addtitle><date>2021-03</date><risdate>2021</risdate><volume>23</volume><issue>3</issue><spage>481</spage><epage>488</epage><pages>481-488</pages><issn>1524-6175</issn><eissn>1751-7176</eissn><abstract>The prevalence of erectile dysfunction (ED) is above 40% in both Asian and non‐Asian male populations after the age of 40 years. The prevalence of ED among hypertensive patients is approximately double than that in normotensive population. Pelvic arterial insufficiency is the predominant cause of ED in men aged over 50 years. Stenosis in any segment of the iliac–pudendal–penile arterial system, which is considered an erectile‐related arterial axis, could lead to ED. Pharmacotherapy with lifestyle modification is effective in alleviating sexual dysfunction, yet a substantial number of patients still develop ED. Given the established applicability of angioplasty for the entire iliac–pudendal–penile arterial system, penile duplex ultrasound, and pelvic computed tomography angiography could be considered as the routine screening tools in ED patients with poor response to phosphodiesterase‐5 inhibitors. Endovascular therapy for pelvic arterial insufficiency‐related ED has been shown to be a safe and effective treatment option in patients who have anatomically suitable vessels and functionally significant stenoses. Clinical improvement was achieved in over 60% of patients at one year following pelvic angioplasty in the PERFECT registry from Taiwan. A 30%‐40% restenosis rate in distal internal pudendal and penile arteries remains a hurdle. Angioplasty for pelvic arterial occlusive disease could be considered as a viable approach to arteriogenic ED.</abstract><cop>United States</cop><pub>John Wiley and Sons Inc</pub><pmid>33314715</pmid><doi>10.1111/jch.14123</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-1410-9328</orcidid><orcidid>https://orcid.org/0000-0002-3885-6600</orcidid><orcidid>https://orcid.org/0000-0002-7180-3607</orcidid><orcidid>https://orcid.org/0000-0003-1995-0359</orcidid><orcidid>https://orcid.org/0000-0002-4911-8507</orcidid><orcidid>https://orcid.org/0000-0002-9262-0287</orcidid><orcidid>https://orcid.org/0000-0003-4527-0285</orcidid><orcidid>https://orcid.org/0000-0001-5580-7686</orcidid><orcidid>https://orcid.org/0000-0001-8511-1524</orcidid><orcidid>https://orcid.org/0000-0002-8251-4480</orcidid><orcidid>https://orcid.org/0000-0001-7657-4383</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1524-6175 |
ispartof | The journal of clinical hypertension (Greenwich, Conn.), 2021-03, Vol.23 (3), p.481-488 |
issn | 1524-6175 1751-7176 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_d5a5c54837654291bd9741651f2c7fdc |
source | Wiley Online Library Open Access; PubMed Central |
subjects | Adult Angioplasty Asia Asian patients atherosclerosis Erectile Dysfunction - diagnosis Erectile Dysfunction - epidemiology Erectile Dysfunction - therapy Humans Hypertension Hypertension and Clinical Outcomes Male Review Paper sexual dysfunction Taiwan vascular disease |
title | Hypertension and erectile dysfunction: The role of endovascular therapy in Asia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A07%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypertension%20and%20erectile%20dysfunction:%20The%20role%20of%20endovascular%20therapy%20in%20Asia&rft.jtitle=The%20journal%20of%20clinical%20hypertension%20(Greenwich,%20Conn.)&rft.au=Wang,%20Tzung%E2%80%90Dau&rft.aucorp=HOPE%20Asia%20Network&rft.date=2021-03&rft.volume=23&rft.issue=3&rft.spage=481&rft.epage=488&rft.pages=481-488&rft.issn=1524-6175&rft.eissn=1751-7176&rft_id=info:doi/10.1111/jch.14123&rft_dat=%3Cproquest_doaj_%3E2470025164%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4813-bf5698c22ff1e6298d79bcccaa8b0f10c07c2d8ee43f22ae0e28ddc10c2389083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2470025164&rft_id=info:pmid/33314715&rfr_iscdi=true |